Trials / Completed
CompletedNCT01112371
Contractubex Treatment in Scars After Abdominal Caesarean Section
A Prospective, Single-center, Randomized, Parallel Group Trial to Investigate the Efficacy of Contractubex® Gel, Containing Extractum Cepae, Allantoin, and Heparin, in Scars After Abdominal Caesarean Section
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy of Contractubex® Gel, containing extractum cepae, allantoin and heparin, in the treatment of scars after abdominal Caesarean section compared to untreated scars after abdominal Caesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Contractubex | Contractubex® Gel, containing 10% extractum cepae, 1% allantoin and 50/U of sodium heparin per one gram of gel. Active drug group: The gel will be applied twice daily (morning/evening). Approximately 2 cm of the IMP are applied onto the scar by light massage rubbing carefully until the product is worked in. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2010-04-28
- Last updated
- 2014-04-08
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01112371. Inclusion in this directory is not an endorsement.